208 related articles for article (PubMed ID: 18164870)
21. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
22. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
[TBL] [Abstract][Full Text] [Related]
23. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
24. A disposable OSL dosimeter for in vivo measurement of rectum dose during brachytherapy.
Hayashi H; Kimoto N; Maeda T; Tomita E; Asahara T; Goto S; Kanazawa Y; Shitakubo Y; Sakuragawa K; Ikushima H; Okazaki T; Hashizume T
Med Phys; 2021 Aug; 48(8):4621-4635. PubMed ID: 33760234
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three brachytherapy gynecological intercavitary treatment planning systems.
Concannon PJ; Mermis N; Nguyen L; Palmer MB
Med Dosim; 2004; 29(2):115-7. PubMed ID: 15191758
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
28. In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.
Waldhäusl C; Wambersie A; Pötter R; Georg D
Radiother Oncol; 2005 Dec; 77(3):310-7. PubMed ID: 16226818
[TBL] [Abstract][Full Text] [Related]
29. A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58.
Siebert FA; Born T; Häring S; Seefeld F; Kovács G
Radiother Oncol; 2006 Jun; 79(3):298-303. PubMed ID: 16730084
[TBL] [Abstract][Full Text] [Related]
30. Dose measurement for medical staff with glass dosemeters and thermoluminescence dosemeters during 125I brachytherapy for prostate cancer.
Fujii K; Ko S; Nako Y; Tonari A; Nishizawa K; Akahane K; Takayama M
Radiat Prot Dosimetry; 2011 Mar; 144(1-4):459-63. PubMed ID: 21212076
[TBL] [Abstract][Full Text] [Related]
31. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
Macdonald DM; Lin LL; Biehl K; Mutic S; Nantz R; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):618-24. PubMed ID: 18407429
[TBL] [Abstract][Full Text] [Related]
32. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
33. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
34. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
Stone NN; Potters L; Davis BJ; Ciezki JP; Zelefsky MJ; Roach M; Shinohara K; Fearn PA; Kattan MW; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):341-6. PubMed ID: 18597953
[TBL] [Abstract][Full Text] [Related]
35. Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer.
Das R; Toye W; Kron T; Williams S; Duchesne G
Australas Phys Eng Sci Med; 2007 Sep; 30(3):178-84. PubMed ID: 18044301
[TBL] [Abstract][Full Text] [Related]
36. [Interstitial brachytherapy--initial experiences using 192iridium in short-term therapy].
Jacobs H; Teusch P; Schleppi V; Schmieder A; Moncke G
Strahlentherapie; 1984 Jan; 160(1):8-14. PubMed ID: 6701928
[TBL] [Abstract][Full Text] [Related]
37. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
38. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537
[TBL] [Abstract][Full Text] [Related]
39. Prostate displacement kit: reducing the radiation dose to the rectum.
Kälkner KM; Nilsson J; Lundell M; Levitt S; Nilsson S
Radiother Oncol; 2006 Dec; 81(3):291-3. PubMed ID: 17125860
[TBL] [Abstract][Full Text] [Related]
40. [Measurement of the radiation load to bladder and rectum in gynecological brachytherapy with a mobile radiation source (author's transl)].
Busch M
Strahlentherapie; 1978 Oct; 154(10):681-5. PubMed ID: 694958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
